Internal Medicine, Hematology & Oncology · El Paso, TX
NPI
1639184005
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
7812 Gateway East, Ste. 110
El Paso, TX, 79915
Phone (915) 533-2888
Groups this clinician bills Medicare through
Medicare paid, 2024
$738K
49,534 services
Medicare patients, 2024
191
Average age 74
Drug cost, 2024
$9.9M
1,952 prescriptions
Company payments, 2025
$58K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haroutioun S Shahinian was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,042 times for 13 patients. In total Haroutioun S Shahinian billed 49,534 services in 82 codes, and Medicare paid $738K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-28.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,042 | 13 | $0.09 | $94.33 |
| 36415 Venipuncture Blood Collection | Office | 829 | 177 | $8.65 | $7,171 |
| 85025 Blood Count | Office | 806 | 176 | $7.56 | $6,097 |
| 80053 Clinical Chemistry | Office | 553 | 169 | $10.26 | $5,673 |
| 83615 Clinical Chemistry | Office | 393 | 141 | $5.85 | $2,298 |
| 99214 Office E&M - Established | Office | 382 | 155 | $96.49 | $37K |
| 96367 Intravenous Infusion, Hydration | Office | 330 | 15 | $22.72 | $7,496 |
| 96413 Chemotherapy Administration | Office | 137 | 15 | $101.01 | $14K |
| 96523 Chemotherapy | Office | 123 | 21 | $17.43 | $2,143 |
| 99213 Office E&M - Established | Office | 43 | 39 | $64.70 | $2,782 |
| 99204 Office E&M - New | Office | 18 | 18 | $131.94 | $2,375 |
By year: 2022 $796K for 43,260 services; 2023 $831K for 62,918 services; 2024 $738K for 49,534 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 829 | 177 | $8.65 | $7,171 |
| 85025 Blood Count | 806 | 176 | $7.56 | $6,097 |
| 80053 Clinical Chemistry | 553 | 169 | $10.26 | $5,673 |
| 83615 Clinical Chemistry | 393 | 141 | $5.85 | $2,298 |
Medicare prescription drug claims, 2024
In 2024, the drug Haroutioun S Shahinian prescribed most often to Medicare patients was Eliquis (Apixaban), with 241 prescriptions and refills. In total Haroutioun S Shahinian wrote 1,952 Medicare prescriptions that cost $9.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 241 | 345 | 47 | $201K |
| Anastrozole Generic | 182 | 497 | 50 | $2,857 |
| Hydroxyurea Generic | 141 | 268 | 35 | $5,164 |
| Tamoxifen Citrate Generic | 97 | 258 | 27 | $3,703 |
| Imbruvica Ibrutinib | 93 | 93 | Under 11 | $1.5M |
| Lenalidomide Generic | 59 | 59 | Under 11 | $894K |
| Procrit Epoetin Alfa | 56 | 56 | 15 | $165K |
| Acyclovir Generic | 53 | 53 | 13 | $571 |
| Promacta Eltrombopag Olamine | 53 | 55 | Under 11 | $811K |
| Imatinib Mesylate Generic | 52 | 54 | Under 11 | $5,114 |
| Zarxio Filgrastim-Sndz | 49 | 49 | 12 | $153K |
| Revlimid Lenalidomide | 48 | 48 | 12 | $1.1M |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 47 | 49 | 42 | $657 |
| Jakafi Ruxolitinib Phosphate | 47 | 47 | Under 11 | $857K |
| Dexamethasone Generic | 43 | 57 | 21 | $758 |
Brand drugs: 933 claims; generic drugs: 1,019 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haroutioun S Shahinian $58K ($1,277 in general payments such as food, travel and fees and $56K for research) from 4 companies. The largest payer was INmune Bio Inc. with $56K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.